Sanofi India Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
SANOFI · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Sanofi India's promoters — Hoechst GmbH and Sanofi SA — have separately filed a declaration under SEBI's Takeover Regulations confirming that they, along with persons acting in concert, have not created any encumbrance (such as a pledge or lien) on their equity shares in the company as of 31st March 2025 and up to the date of the filing (26–27 June 2025). This is a routine annual compliance submission required from promoters to confirm their shareholding remains unencumbered. No changes to promoter shareholding, pledge status, or any other action are reported. The declaration is a negative confirmation, indicating the status quo on promoter shareholding remains intact.
No material impact on shareholders or stock price — this is a routine regulatory compliance filing confirming that promoters have not pledged or encumbered their shares, which is generally seen as a neutral-to-positive sign indicating no immediate risk of forced selling or stake changes.